Evidence map›Paper›PMID 34619331›Full record

ArticleInternational journal of radiation oncology, biology, physics2022

Radiosensitizing the Vasculature of Primary Brainstem Gliomas Fails to Improve Tumor Response to Radiation Therapy.

Katherine Deland, Joshua S Mercer, Donna M Crabtree, Maria E Guerra Garcia, Michael Reinsvold, Lorraine Da Silva Campos, Nerissa T Williams, Lixia Luo, Yan Ma, Zachary J Reitman and 2 more

Open access · greenAbstract read
In one paragraph

Article in International journal of radiation oncology, biology, physics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. The Effect ofCancers · 2022
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Katherine DelandDepartment of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.
Joshua S MercerDepartment of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.
Donna M CrabtreeDepartment of Pediatrics, Duke University Medical Center, Durham, North Carolina.
Maria E Guerra GarciaDepartment of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.
Michael ReinsvoldDepartment of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.
Lorraine Da Silva CamposDepartment of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.
Nerissa T WilliamsDepartment of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.
Lixia LuoDepartment of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.
Yan MaDepartment of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.
Zachary J ReitmanDepartment of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.
Oren J BecherDepartment of Pediatrics, Northwestern University, Chicago, Illinois; Department of Biochemistry and Molecular Genetics, Northwestern University, Chicago, Illinois; Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.
David G KirschDepartment of Radiation Oncology, Duke University Medical Center, Durham, North Carolina; Department of Pharmacology & Cancer Biology, Duke University Medical Center, Durham, North Carolina. Electronic address: david.kirsch@duke.edu.
Duke Medical Center · USNorthwestern University · US

Funding

Targeted Alpha-Particle Radiotheraphy of Brain Tumors with 211At-81C6 AntibodyP50CA190991 · NCI · DUKE UNIVERSITY · PI SAMPSON, JOHN H. · 2014 to 2023
$20.8M
Advancing Cancer Therapy through Ground Breaking Research in Radiation BiologyR35CA197616 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI David Guy Kirsch · 2016 to 2026
$10.7M
Image-Guided Radiation Therapy System for Small AnimalsS10OD028575 · OD · DUKE UNIVERSITY · PI PALMER, GREGORY MATHEW · 2021 to 2021
$600k
NCI NIH HHS P50 CA190991NCI NIH HHS R35 CA197616NIH HHS S10 OD028575
6 · The paper itself

Abstract

purposeDiffuse intrinsic pontine gliomas (DIPGs) arise in the pons and are the leading cause of death from brain tumors in children. DIPGs are routinely treated with radiation therapy, which temporarily improves neurological symptoms but generally fails to achieve local control. Because numerous clinical trials have not improved survival from DIPG over standard radiation therapy alone, there is a pressing need to evaluate new therapeutic strategies for this devastating disease. Vascular damage caused by radiation therapy can increase the permeability of tumor blood vessels and promote tumor cell death. METHODS AND MATERIALS: To investigate the impact of endothelial cell death on tumor response to radiation therapy in DIPG, we used dual recombinase (Cre + FlpO) technology to generate primary brainstem gliomas which lack ataxia telangiectasia mutated (Atm) in the vasculature.

resultsHere, we show that Atm-deficient tumor endothelial cells are sensitized to radiation therapy. Furthermore, radiosensitization of the vasculature in primary gliomas triggered an increase in total tumor cell death. Despite the observed increase in cell killing, in mice with autochthonous DIPGs treated with radiation therapy, deletion of Atm specifically in tumor endothelial cells failed to improve survival.

conclusionsThese results suggest that targeting the tumor cells, rather than endothelial cells, during radiation therapy will be necessary to improve survival among children with DIPG.

Indexed as

Brain Stem NeoplasmsGliomaAnimalsEndothelial CellsMice

Identifiers

PMID34619331
PMCPMC8898173
OpenAlexW3203058579

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.